Home » Authors » James Etheridge

James Etheridge

Articles

ARTICLES

France Biotech Condemns Research Tax 'Scandal'

Dec. 5, 2007

By James Etheridge

Fovea Enters Ophthalmology Collaboration with Genzyme

Nov. 28, 2007

By James Etheridge

Fovea Enters Ophthalmology Collaboration with Genzyme

Nov. 28, 2007

By James Etheridge

Cerep Sells Hesperion To CRO Averion In €25M Deal

Nov. 14, 2007

By James Etheridge

Cerep Sells Hesperion To CRO Averion In €25M Deal

Nov. 14, 2007

By James Etheridge

No Abstract

Diatos Releases Doxorubicin Data, Delves Into Toxicology

Oct. 24, 2007

By James Etheridge

Diatos Releases Doxorubicin Data, Delves Into Toxicology

Oct. 24, 2007

By James Etheridge

Cellectis and Servier Enter Cell Engineering Alliance

Oct. 17, 2007

By James Etheridge

Cellectis and Servier Enter Cell Engineering Alliance

Oct. 17, 2007

By James Etheridge

French Biotech Growing But Still Lagging Behind

Oct. 10, 2007

By James Etheridge

View All Articles by James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.